Alzamend Neuro (ALZN) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free ALZN Stock Alerts $0.71 -0.02 (-2.74%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alzamend Neuro (NASDAQ:ALZN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage52.22%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$47,391.59Number OfInsiders Selling(Last 12 Months)0 Get ALZN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALZN Insider Buying and Selling by Quarter Ad Schaeffer’s ResearchJust Released: Insider's Secret to Trading OptionsThis Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.Yes! Show Me This Strategy Alzamend Neuro Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/19/2024Milton C Ault IIIDirectorBuy1,000$0.69$690.00 4/1/2024Milton C Ault IIIDirectorBuy334$0.91$303.94 1/5/2024Milton C Ault IIIDirectorBuy5,000$1.02$5,100.00 12/26/2023Milton C Ault IIIMajor ShareholderBuy500$0.90$450.00 12/22/2023Milton C Ault IIIMajor ShareholderBuy200$0.92$184.00 9/26/2023David J KatzoffCFOBuy3,533$2.85$10,069.05 5/24/2023Milton C Ault IIIMajor ShareholderBuy1,200$8.85$10,620.00 4/28/2023Stephan JackmanCEOBuy2,466$8.10$19,974.60 (Data available from 1/1/2013 forward) ALZN Insider Trading Activity - Frequently Asked Questions Who is on Alzamend Neuro's Insider Roster? The list of insiders at Alzamend Neuro includes David J Katzoff, Lynne Fahey Mcgrath, Mark Gustafson, Milton C Ault III, and Stephan Jackman. Learn more on insiders at ALZN. What percentage of Alzamend Neuro stock is owned by insiders? 52.22% of Alzamend Neuro stock is owned by insiders. Learn more on ALZN's insider holdings. Which Alzamend Neuro insiders have been buying company stock? The following insiders have purchased ALZN shares in the last 24 months: David J Katzoff ($21,157.95), Lynne Fahey Mcgrath ($4,295.70), Milton C Ault III ($4,320,765.89), and Stephan Jackman ($30,417.30). How much insider buying is happening at Alzamend Neuro? Insiders have purchased a total of 214,517 ALZN shares in the last 24 months for a total of $4,376,636.84 bought. More Insider Trading Tools from MarketBeat Related Companies: Exicure Insider Trading Seelos Therapeutics Insider Trading Kineta Insider Trading Oragenics Insider Trading Sonnet BioTherapeutics Insider Trading GT Biopharma Insider Trading Synaptogenix Insider Trading Soligenix Insider Trading Avenue Therapeutics Insider Trading PaxMedica Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ALZN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.